In human medicine, S100A12 has been reported to be a sensitive and specific marker of localized inflammatory disease processes, such as gastrointestinal inflammation, and to be increased in fecal samples from patients with IBD (active Crohn’s disease and ulcerative colitis) [16, 17]. The gene discussed is S100A12; the disease is inflammatory bowel disease.